Label Free Detection Market Analysis, Development, Growth and Demand Forecast to 2020 by P&S Market ResearchPharmaceutical InformationUpdated on Apr 2, 2016 View more like this | Visit NEW YORK, NY | Contact Global Trends |
The global label free detection market is growing significantly due rise in contract research organization in emerging economies, and increasing government funding and grants in the industry. Increasing drug discovery programs through research partnerships between pharmaceutical companies and academic institutes are also supporting the growth of the market. Massive unexplored market in label free detection industry of developing economies are creating significant opportunities for the label free detection market to grow during the forecasted period.
Explore more or request TOC on Global Label Free Detection Market at: https://www.psmarketresearch.com/market-analysis/label-free-detection-market
Moreover, the advanced research and development facilities, and new and innovative product developments by the companies are also propelling the growth of the label free detection industry. Label free technologies are mainly used in drug discoveries and detection of molecular interactions. It is a highly precise method for the recognition of endogenous targets in cell assay.
The label free detection market is categorized on the basis of technology, application, products and end users. On the basis technology of label free detection, the market can be categorized as optical waveguide grating technology, surface plasmon resonance, cellular dielectric spectroscopy, bio-layer interferometry and others technologies. Surface plasmon resonance leads the market, as this technology is highly employed in drug discovery and development for getting into molecular binding mechanism and biological processes. Whereas, bio-layer interferometry is expected to grow at fastest rate due to increasing usage of technology in lifescience research for ligand binding studies. Based on application, the label free detection market can be segmented as lead generation, binding kinetics, hit confirmation, endogenous receptors detection, binding thermodynamics, and others.
On the basis of products, the market is segmented as consumables and instruments. Instruments lead the market, in terms of size, due to increasing purchase of instruments in pharmaceutical and biotechnology companies; whereas, consumables are expected to grow at faster rate due to advancement in drug discovery. Consumables include biosensor chips and microplates. Moreover, on the basis of end users, the market is categorized as academic research institutes, contract research organization, pharmaceutical and biotechnology companies, and others. Pharmaceutical and biotechnology companies lead the market, whereas contract research organizations are expected to grow at fastest rate due to increasing outsourcing of drug dioscovery.
Some of the factors driving the growth of global label free detection market are increasing research and development budgets of pharmaceutical companies, increasing pharmaceutical outsourcing, increasing biomolecular interaction analysis in drug discovery, intrinsic advantages of label free detection over alternative technologies, such as flow cytometry, and ELISA, and increasing drug discoveries programs. However, lack of skilled professionals, and high cost of instruments are some of the factors restraining the growth of the global label free detection market.
Geographically, North America will be leading the global label free detection market in the coming years, due to increasing research and development spending. Asia-Pacific is the fastest growing region in the global label free detection market. The major reasons for the fastest growth of label free detection market in the region are increasing healthcare expenditure, improving healthcare infrastructure, increasing research and development funding, and large pool of patients in the region. Moreover, the label free detection market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China, of Asia-Pacific region.
Browse related market research at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the companies operating in the global label free detection market are Pall Corporation, Roche Diagnostics, Bio-Rad Laboratories, Inc., General Electric, X-Body Biosciences, Ametek, Inc., Bioptix, Corning, Inc., Attana AB, Danaher Corporation, and Perkinelmer, Inc.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: [email protected]
Web: https://www.psmarketresearch.com
Explore more or request TOC on Global Label Free Detection Market at: https://www.psmarketresearch.com/market-analysis/label-free-detection-market
Moreover, the advanced research and development facilities, and new and innovative product developments by the companies are also propelling the growth of the label free detection industry. Label free technologies are mainly used in drug discoveries and detection of molecular interactions. It is a highly precise method for the recognition of endogenous targets in cell assay.
The label free detection market is categorized on the basis of technology, application, products and end users. On the basis technology of label free detection, the market can be categorized as optical waveguide grating technology, surface plasmon resonance, cellular dielectric spectroscopy, bio-layer interferometry and others technologies. Surface plasmon resonance leads the market, as this technology is highly employed in drug discovery and development for getting into molecular binding mechanism and biological processes. Whereas, bio-layer interferometry is expected to grow at fastest rate due to increasing usage of technology in lifescience research for ligand binding studies. Based on application, the label free detection market can be segmented as lead generation, binding kinetics, hit confirmation, endogenous receptors detection, binding thermodynamics, and others.
On the basis of products, the market is segmented as consumables and instruments. Instruments lead the market, in terms of size, due to increasing purchase of instruments in pharmaceutical and biotechnology companies; whereas, consumables are expected to grow at faster rate due to advancement in drug discovery. Consumables include biosensor chips and microplates. Moreover, on the basis of end users, the market is categorized as academic research institutes, contract research organization, pharmaceutical and biotechnology companies, and others. Pharmaceutical and biotechnology companies lead the market, whereas contract research organizations are expected to grow at fastest rate due to increasing outsourcing of drug dioscovery.
Some of the factors driving the growth of global label free detection market are increasing research and development budgets of pharmaceutical companies, increasing pharmaceutical outsourcing, increasing biomolecular interaction analysis in drug discovery, intrinsic advantages of label free detection over alternative technologies, such as flow cytometry, and ELISA, and increasing drug discoveries programs. However, lack of skilled professionals, and high cost of instruments are some of the factors restraining the growth of the global label free detection market.
Geographically, North America will be leading the global label free detection market in the coming years, due to increasing research and development spending. Asia-Pacific is the fastest growing region in the global label free detection market. The major reasons for the fastest growth of label free detection market in the region are increasing healthcare expenditure, improving healthcare infrastructure, increasing research and development funding, and large pool of patients in the region. Moreover, the label free detection market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China, of Asia-Pacific region.
Browse related market research at: https://www.psmarketresearch.com/industry-report/healthcare
Some of the companies operating in the global label free detection market are Pall Corporation, Roche Diagnostics, Bio-Rad Laboratories, Inc., General Electric, X-Body Biosciences, Ametek, Inc., Bioptix, Corning, Inc., Attana AB, Danaher Corporation, and Perkinelmer, Inc.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
US/ Canada Toll-Free: 1-888-778-7886
Email: [email protected]
Web: https://www.psmarketresearch.com
